CRMA and cancer: We transduced cancer cells to overexpress crmA which inhibits initiator caspases including caspase-1 and caspase-8 in the death-receptor pathway [16], or Bcl-2, a well-known inhibitor of multiple caspases in the mitochondrial pathway [17].